Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity.

This work describes how to tune the amphiphilic conformation of α-mangostin, a natural compound that contains a hydrophobic xanthone scaffold, to improve its antimicrobial activity and selectivity for Gram-positive bacteria. A series of xanthone derivatives was obtained by cationic modification of the free C3 and C6 hydroxyl groups of α-mangostin with amine groups of different pKa values. Modified structures using moieties with high pKa values, such as AM-0016 (3b), exhibited potent antimicrobial properties against Gram-positive bacteria. Compound 3b also killed bacteria rapidly without inducing drug resistance and was nontoxic when applied topically. Biophysical studies and molecular dynamics simulations revealed that 3b targets the bacterial inner membrane, forming an amphiphilic conformation at the hydrophobic-water interface. In contrast, moieties with low pKa values reduced the antimicrobial activity of the parent compound when conjugated to the xanthone scaffold. This strategy provides a new way to improve "hits" for the development of membrane-active antibiotics that target drug-resistant pathogens.

[1]  Sunil K. Vooturi,et al.  Synthetic membrane-targeted antibiotics. , 2010, Current medicinal chemistry.

[2]  Effect of structural parameters of peptides on dimer formation and highly oxidized side products in the oxidation of thiols of linear analogues of human β‐defensin 3 by DMSO , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[3]  J. Rolain,et al.  Synthesis of new 3,20-bispolyaminosteroid squalamine analogues and evaluation of their antimicrobial activities. , 2011, Journal of medicinal chemistry.

[4]  S. Vooturi,et al.  Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents. , 2009, Journal of medicinal chemistry.

[5]  H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[6]  H. Gold,et al.  Antimicrobial resistance to linezolid. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Michael A Fischbach,et al.  New antibiotics from bacterial natural products , 2006, Nature Biotechnology.

[8]  H. Kauffmann,et al.  Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin , 2007, Human & experimental toxicology.

[9]  G. Tew,et al.  Antimicrobial activity of an abiotic host defense peptide mimic. , 2006, Biochimica et biophysica acta.

[10]  P. Savage Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria , 2001, Annals of medicine.

[11]  K. Schofield,et al.  Heteroaromatic Nitrogen Compounds: The Azoles , 1967 .

[12]  S. Yenugu,et al.  The Androgen-Regulated Epididymal Sperm-Binding Protein, Human β-Defensin 118 (DEFB118) (Formerly ESC42), Is an Antimicrobial β-Defensin , 2004 .

[13]  C. Verma,et al.  Progressive Structuring of a Branched Antimicrobial Peptide on the Path to the Inner Membrane Target* , 2012, The Journal of Biological Chemistry.

[14]  R. S. Coleman,et al.  Synthesis of Secondary Amines , 2007 .

[15]  M. Robbins,et al.  Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study , 2010, Antimicrobial Agents and Chemotherapy.

[16]  P. Savage,et al.  Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. , 2001, The Journal of antimicrobial chemotherapy.

[17]  A. Pini,et al.  Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity , 2007, Journal of peptide science : an official publication of the European Peptide Society.

[18]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[19]  Ping Shen,et al.  Epidemiology and characteristics of antimicrobial resistance in China. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[20]  Robert Gurny,et al.  Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. , 2000, International journal of pharmaceutics.

[21]  R. Hancock,et al.  Interaction of the Cyclic Antimicrobial Cationic Peptide Bactenecin with the Outer and Cytoplasmic Membrane* , 1999, The Journal of Biological Chemistry.

[22]  P. Savage,et al.  Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. , 2002, Journal of medicinal chemistry.

[23]  T. Beveridge,et al.  Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus , 2008, Antimicrobial Agents and Chemotherapy.

[24]  M. Nakamura,et al.  Effects of antimicrobials on corneal epithelial migration. , 1993, Current eye research.

[25]  R. Beuerman,et al.  The effect of collagen shields on epithelial wound healing in rabbits. , 1989, American journal of ophthalmology.

[26]  W. DeGrado,et al.  Orientation, dynamics, and lipid interaction of an antimicrobial arylamide investigated by 19F and 31P solid-state NMR spectroscopy. , 2010, Journal of the American Chemical Society.

[27]  Y. Sakagami,et al.  Antibacterial activity of xanthones from Garcinia mangostana (L.) and their structure–activity relationship studies , 2013, Natural product research.

[28]  G. Tew,et al.  Influence of lipid composition on membrane activity of antimicrobial phenylene ethynylene oligomers. , 2008, The journal of physical chemistry. B.

[29]  M. Yamada,et al.  Corneal ulcer associated with deposits of norfloxacin. , 1998, American journal of ophthalmology.

[30]  S. Cosgrove,et al.  The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.

[31]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[32]  C. Verma,et al.  Linear Analogues of Human β‐Defensin 3: Concepts for Design of Antimicrobial Peptides with Reduced Cytotoxicity to Mammalian Cells , 2008, Chembiochem : a European journal of chemical biology.

[33]  J. Reidy,et al.  Effect of topical beta blockers on corneal epithelial wound healing in the rabbit. , 1994, British Journal of Ophthalmology.

[34]  Y. Ishitsuka,et al.  Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion. , 2006, Journal of the American Chemical Society.

[35]  Y. Pouliquen,et al.  Antibiotics and corneal epithelial wound healing. , 1983, Archives of ophthalmology.

[36]  C. Coopersmith,et al.  Epithelial cells , 1991 .

[37]  J. Etter,et al.  Biopharmaceutical test of ocular irritation in the mouse. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  P. Savage,et al.  Antimicrobial Activities of Ceragenins against Clinical Isolates of Resistant Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[39]  L. Gutmann,et al.  In Vitro Bactericidal Activities of Linezolid in Combination with Vancomycin, Gentamicin, Ciprofloxacin, Fusidic Acid, and Rifampin against Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[40]  William J. Allen,et al.  Practical Considerations for Building GROMOS-Compatible Small-Molecule Topologies , 2010, J. Chem. Inf. Model..

[41]  A. Kinghorn,et al.  Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). , 2006, Journal of agricultural and food chemistry.

[42]  H. Taylor,et al.  Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. , 2001, American journal of ophthalmology.

[43]  M. Vaara,et al.  Agents that increase the permeability of the outer membrane. , 1992, Microbiological reviews.

[44]  Ramesh Rathinakumar,et al.  Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. , 2009, Journal of the American Chemical Society.

[45]  V. Adhami,et al.  α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. , 2012, Carcinogenesis.

[46]  P. Barie,et al.  Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. , 2011, International journal of antimicrobial agents.

[47]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.

[48]  W. Bocian,et al.  Genistein binding mode to doubly nicked dumbbell DNA. Dynamic and diffusion ordered NMR study. , 2011, Journal of medicinal chemistry.

[49]  I. Vattulainen,et al.  Role of phosphatidylglycerols in the stability of bacterial membranes. , 2008, Biochimie.

[50]  A. Resch,et al.  The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals , 2009, The European Journal of Health Economics.

[51]  S. Gad,et al.  Acute toxicology testing , 1997 .

[52]  D. Tan,et al.  Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting. , 2013, Biochimica et biophysica acta.

[53]  S. Klyce,et al.  Epithelial wound closure in the rabbit cornea. A biphasic process. , 1986, Investigative ophthalmology & visual science.

[54]  I. Chopra,et al.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.

[55]  Stefan Weigand,et al.  Antibacterial natural products in medicinal chemistry--exodus or revival? , 2006, Angewandte Chemie.

[56]  D. Weibel,et al.  DCAP: A Broad‐spectrum Antibiotic that Targets the Cytoplasmic Membrane of Bacteria , 2012, Journal of the American Chemical Society.

[57]  R. Nordquist,et al.  Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. , 2001, Journal of cataract and refractive surgery.

[58]  R. Gennaro,et al.  Cathelicidin peptides as candidates for a novel class of antimicrobials. , 2002, Current pharmaceutical design.

[59]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[60]  William C Wimley,et al.  Describing the mechanism of antimicrobial peptide action with the interfacial activity model. , 2010, ACS chemical biology.

[61]  T. Tan,et al.  Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteraemia in Singapore. , 2010, Journal of medical microbiology.

[62]  R. Beuerman,et al.  Human recombinant epidermal growth factor in experimental corneal wound healing. , 1991, Investigative ophthalmology & visual science.

[63]  S. Yenugu,et al.  The androgen-regulated epididymal sperm-binding protein, human beta-defensin 118 (DEFB118) (formerly ESC42), is an antimicrobial beta-defensin. , 2004, Endocrinology.

[64]  M. Poot,et al.  Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain , 1997, Applied and environmental microbiology.

[65]  Pramod C. Nair,et al.  An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0. , 2011, Journal of chemical theory and computation.

[66]  L. Guo,et al.  The structural parameters for antimicrobial activity, human epithelial cell cytotoxicity and killing mechanism of synthetic monomer and dimer analogues derived from hBD3 C-terminal region , 2010, Amino Acids.

[67]  D. Albert,et al.  In vitro toxicity of gentamicin to corneal epithelial cells. , 1990, Cornea.

[68]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[69]  M. Maia,et al.  Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part II: Retinal Toxicity of Current and New Drugs , 2010, Ophthalmic Research.

[70]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[71]  H. Hall,et al.  Correlation of the Base Strengths of Amines1 , 1957 .

[72]  R. Hancock Host defence (cationic) peptides: what is their future clinical potential? , 1999, Drugs.

[73]  B. Levin,et al.  Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae , 2006, Antimicrobial Agents and Chemotherapy.

[74]  M. Havelková,et al.  Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides. , 2010, Journal of medicinal chemistry.

[75]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[76]  B. Brandsdal,et al.  A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption. , 2011, Journal of medicinal chemistry.